期刊文献+

干扰素治疗老年丙型病毒性肝炎的临床分析 被引量:9

下载PDF
导出
摘要 目的观察老年慢性丙型病毒性肝炎患者干扰素治疗的临床特点与疗效。方法选取53例老年丙肝患者,对比36例中青年丙肝患者抗病毒治疗前后系列生化及病毒载量变化。结果病毒应答率老年组早期病毒应答(EVR)、治疗结束时病毒学应答(ETVR)、持续性病毒学应答(SVR)分别为20.8%、41.5%、79.2%、69.8%,肝功复常率老年组低于对照组,两组差异无统计学意义(P>0.05)。抑郁、白细胞计数降低以及心电图改变的发生率高于对照组(P<0.05)。结论老年丙肝患者抗病毒治疗无论普通还是长效干扰素其SVR与年轻人相同,治疗6个月时疗效欠佳和明显的不良事件发生成为能否坚持用药的关键点。加强监测和心理疏导,必要时应用抗抑郁药物有助于提高依从性。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第13期3033-3035,共3页 Chinese Journal of Gerontology
基金 北京市自然科学基金(No.7112064)
  • 相关文献

参考文献8

二级参考文献15

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2Fried MW, Hadziyannis SJ. Treatment of chronic hepatitis C. Hwpatology,2002,36(5 suppl) :135-144.
  • 3Kojima H, Hongo Y. Long-term histological prognosis and serum fibrsis markers in chronic hepatitis C patients treated with inter-feron. J Gastroenterol Hepatol,2001,16(9 ) : 1015-1021.
  • 4Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and tr-Eatment of hepatitis C : an update. Hepatology, 2009,49 (4) :1335-1339.
  • 5Feid JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin Intreatment of hepatitis C. Nature ,2005,436:967-972.
  • 6Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, manage- ment, and treatment of hepatitis C: an updata[J]. Hepatology, 2009, 49(4) 1335 -1374.
  • 7Marcus EL, Tur- Kaspa R. Chronic Hepatitis C virus infection in older adults[J]. Clin Infect Dis, 2005, 41 (11) 1606 -1612.
  • 8Iwasaki Y, Ikeda H, Araki Y, et al. Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C[J]. Hepatology, 2006, 43(1 ) : 54 -63.
  • 9McHutchison JG, Manns MP, Brown RS. Strategies for manag- ing anemia in hepatitis C patients undergoing antiviral therapy [J]. Am J Gastroenterol, 2007, 102(4) : 880 -889.
  • 10Honda T, Katano Y, Shimizu J, et al. Efficacy of peginterfer- on -α -2b plus ribavirin in patients aged 65 years and older with chronic hepatitis[ J]. Liver Int, 2010, 30 (4) 527- 537.

共引文献45

同被引文献46

  • 1李杰,庄辉.病毒性肝炎流行病学进展[J].中国继续医学教育,2011,3(6):1-4. 被引量:8
  • 2吴卫锋,孙薇薇.α-2b干扰素联合复方甘草酸苷治疗慢性丙型病毒性肝炎疗效观察[J].中国药房,2004,15(9):558-559. 被引量:7
  • 3丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 4Lemon SM,McKeating JA,Pietschmann T,et al.Development of noveltherapies for hepatitis C[J].Antiviral Research,2010,86(1):79-92.
  • 5Burlone ME,Budkowska A.Hepatitis C virus cell entry:role of lipopro-teins and cellular receptors[J].Journal of General Virology,2009,90(5):1055-1070.
  • 6Sulkowski MS?HeindolIar R,Thomas DL.Combination therapy with pegin-terferon alfa-2a(Pegasys)and ribavirin in ther treatment of patients withchronic hepatitis C:a phase II open -label study[J].Bio Drugs,2002,16(4):105-109.
  • 7Ghany MG,Strader DB,Thomas DL,et al.Diagnosis,management,andtreatment of hepatitis C:an update[J].Hepatology,2009,49(4):1335-1374.
  • 8CraxiA.EASL clinical practice guidelines:management of hepatitis C[J].J Hepatol,2011,55(2):245-264.
  • 9McCaughan GW,Omata M,Araarapurkar D,et al.Asian Pacific Associa-tion for the Study of the Liver consensus statements on the diagnosis,management and treatment of hepatitis C virus infection[J].Journal ofgastroenterology and hepatology,2007,22:615-633.
  • 10严喜章.PEG-IFNα联合利巴韦林治疗慢性丙型肝炎37例临床观察[J].山东医药,2010,50(23):89-90. 被引量:2

引证文献9

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部